Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12283711 | 1.00 | ACHE (0.40) | ACHETDP1ALDH1A1IDO1GAA | |
| SCHEMBL20906472 | 0.82 | ACHE (0.42) | ACHETDP1ALDH1A1IDO1GAA | |
| SCHEMBL20921311 | 0.82 | ACHE (0.42) | ACHETDP1ALDH1A1IDO1GAA | |
| SCHEMBL6319958 | 0.81 | ACHE (0.36) | ACHETDP1ALDH1A1IDO1GAA | |
| SCHEMBL7332889 | 0.78 | LMNA (0.38) | TDP1ALDH1A1IDO1ELANECYP3A4 | |
| SCHEMBL11092898 | 0.78 | ACHE (0.38) | ACHETDP1ALDH1A1IDO1GAA | |
| SCHEMBL20590378 | 0.78 | CYP2A6 (0.38) | ALDH1A1GAAMAPTCA1CA2 | |
| SCHEMBL20226629 | 0.78 | GAA (0.40) | ACHETDP1ALDH1A1GAACYP3A4 | |
| SCHEMBL17447443 | 0.78 | CYP1A2 (0.39) | ACHETDP1ALDH1A1IDO1GAA | |
| SCHEMBL7474191 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6838019-B2 | Phosphorescent material and electroluminescent device using thereof | RITEK CORPORATION (TW) | 2005-01-04 | — | — | US | claimed |
| US-20030102800-A1 | Phosphorescent material | RITEK CORPORATION (TW) | 2003-06-05 | — | — | US | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| EP-4206175-A1 | PREPARATION OF SUBSTITUTED ACRYLATE COMPOUND | Hua Medicine (Shanghai) Ltd. (CN) | 2023-07-05 | — | — | EP | disclosed |
| US-20220267283-A1 | HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-08-25 | — | — | US | disclosed |
| US-11345670-B2 | Heterocyclic compounds for cancer imaging and treatment and methods for their use | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-05-31 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-20210387957-A1 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-12-16 | — | — | US | disclosed |
| WO-2021127333-A1 | TRPML MODULATORS | CASMA THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| US-20200325106-A1 | HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-10-15 | — | — | US | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-7456311-B2 | Adamantane derivative, process for producing the same, and photosensitive material for photoresist | IDEMITSU KOSAN CO., LTD. (JP) | 2008-11-25 | — | — | US | disclosed |
| US-20080188452-A1 | Macrocyclic Benzofused Pyrimidine Derivatives | ABBVIE INC. | 2008-08-07 | — | — | US | disclosed |
| US-20080009647-A1 | Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist | IDEMITSU KOSAN CO., LTD. (JP) | 2008-01-10 | — | — | US | disclosed |
| EP-1803708-A1 | ADAMANTANE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PHOTOSENSITIVE MATERIAL FOR PHOTORESIST | IDEMITSU KOSAN CO., LTD. (JP) | 2007-07-04 | — | — | EP | disclosed |
| CN-1288222-C | Phosphorescent light-emitting material | LAIDE SCIENCE & TECHNOLOGY CO (CN) | 2006-12-06 | — | — | CN | disclosed |
| US-6838019-B2 | Phosphorescent material and electroluminescent device using thereof | RITEK CORPORATION (TW) | 2005-01-04 | — | — | US | disclosed |
| CN-1464027-A | Phosphorescent light-emitting material | LAIDE SCIENCE & TECHNOLOGY CO (CN) | 2003-12-31 | — | — | CN | disclosed |
| US-20030102800-A1 | Phosphorescent material | RITEK CORPORATION (TW) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210387957-A1 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | AR, SHBG, NR5A1 | ACHE 4517/4885TDP1 1267/4885ALDH1A1 492/4885 |
| US-11345670-B2 | Heterocyclic compounds for cancer imaging and treatment and methods for their use | AR, KLK3, GNRHR | ACHE 3643/4885TDP1 745/4885ALDH1A1 668/4885 |
| US-20080188452-A1 | Macrocyclic Benzofused Pyrimidine Derivatives | DPYD, TYMS, UMPS | ACHE 3918/4885TDP1 604/4885ALDH1A1 411/4885 |
| US-20220267283-A1 | HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE | AR, KLK3, GNRHR | ACHE 3643/4885TDP1 745/4885ALDH1A1 668/4885 |
| US-20080009647-A1 | Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist | LSS, C1S, DHPS | ACHE 2358/4885TDP1 2649/4885ALDH1A1 1544/4885 |
| US-20200325106-A1 | HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE | AR, KLK3, GNRHR | ACHE 3643/4885TDP1 745/4885ALDH1A1 668/4885 |
| US-20030102800-A1 | Phosphorescent material | PKD1, RPS6KA1, RPS6KA6 | ACHE 4774/4885TDP1 4727/4885ALDH1A1 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.